Can biomarkers advance HIV research and care in the antiretroviral therapy era

Keyphrases

• Chronic Inflammation 100%
• Antiretroviral Therapy 100%
• HIV Care 100%
• HIV Research 100%
• Trialists 100%
• HIV Infection 50%
• Aging 50%
• Inflammation 50%
• Cardiovascular Disease 50%
• CD4+ T 50%
• Below Level 50%
• Long-term Treatment 50%
• Liver Disease 50%
• Human Immunodeficiency Virus Type 1 (HIV-1) 50%
• Renal Disease 50%
• Operational Definition 50%
• Epidemiologist 50%
• Chronic HIV Infection 50%
• Intervention Studies 50%
• Clinical Management 50%
• Osteoporosis 50%
• Weight Gain 50%
• Translational Scientist 50%
• HIV-associated 50%
• Hypercoagulability 50%
• Cell Count 50%
• Treatment Toxicity 50%
• Non-AIDS Events 50%
• Detection Rate 50%
• Multiple Biomarkers 50%
• Immune Dysfunction 50%
• Therapeutic Discovery 50%
• Trial Management 50%
• ART Initiation 50%
• Index Weight 50%
• New Biomarkers 50%
• Neurocognitive Decline 50%
• Aging with HIV 50%
• Guided Therapy 50%
• Guided Discovery 50%

Medicine and Dentistry

• Human Immunodeficiency Virus 100%
• Biological Marker 100%
• Antiretroviral Therapy 100%
• Human Immunodeficiency Virus Infection 33%
• Chronic Inflammation 33%
• Malignant Neoplasm 16%
• Cardiovascular Disease 16%
• T-Helper Cell 16%
• Liver Disease 16%
• Epidemiologist 16%
• Clinical Management 16%
• Nephropathy 16%
• Osteoporosis 16%
• Hypercoagulability 16%
• Human Immunodeficiency Virus 1 16%
• Cell Count 16%
• Immune Disorder 16%
• Intervention Trial 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Biological Marker 100%
• HIV 100%
• Human Immunodeficiency Virus Infection 33%
• Chronic Inflammation 33%
• Malignant Neoplasm 16%
• Liver Disease 16%
• Inflammation 16%
• Kidney Disease 16%
• Hypercoagulability 16%
• Human Immunodeficiency Virus 1 16%
• Intervention Trial 16%
• Cardiovascular Disease 16%